Poop transplant trial aims to rescue lungs from superbug infections
NCT ID NCT06970262
Summary
This study is testing whether a fecal microbiota transplant (FMT) can help critically ill ICU patients with severe, drug-resistant lung infections. Researchers will transfer gut bacteria from healthy donors to patients via a feeding tube, aiming to restore a healthy balance of bacteria in both the gut and lungs. The goal is to see if this approach improves patient recovery, reduces time in the ICU, and lowers the risk of death.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MICROBIAL COLONIZATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, China
Contact
Conditions
Explore the condition pages connected to this study.